National Centre for Pharmacoeconomics

National Centre for

NCPE Ireland

Cannabidiol is indicated for use as adjunctive therapy of seizures associated with Lennox-Gastaut Syndrome in conjunction with clobazam, for patients two years of age and older.


NCPE Assessment Process Complete
Rapid review commissioned 05/02/2020
Rapid review completed 11/03/2020
Rapid Review outcome A full HTA is recommended to assess the clinical effectiveness and cost effectiveness of cannabidiol compared with the current standard of care.